Omalizumab in Chronic Urticaria: A Comprehensive Review

Turkderm Deri Hastaliklari ve Frengi Arsivi - Turkey
doi 10.4274/turkderm.26987
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Galenos Yayinevi

Related search

Omalizumab vs. Placebo in the Management of Chronic Idiopathic Urticaria: A Systematic Review

World Allergy Organization Journal
ImmunologyPulmonaryAllergyRespiratory Medicine
2014English

Omalizumab Treatment in Patients With Chronic Spontaneous Urticaria

Bőrgyógyászati és Venerológiai Szemle
2015English

Efficacy of Omalizumab in Treatment-Resistant Chronic Spontaneous Urticaria

Asim, Allerji, Immunoloji
Respiratory MedicinePulmonaryAllergyImmunology
2018English

The Efficacy of Omalizumab Therapy in Chronic Spontaneous Urticaria: A Retrospective Analysis

Turkderm Deri Hastaliklari ve Frengi Arsivi
DermatologyInfectious Diseases
2019English

Re-Evaluation of Need and Tapering of Omalizumab in Chronic Idiopathic Urticaria

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Omalizumab for Chronic Idiopathic Urticaria: Potential to Taper Dose and Frequency?

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Strategies for Discontinuing Omalizumab in Patients With Chronic Urticaria: Real-World Findings

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Transient Hair Loss in Patients With Chronic Spontaneous Urticaria Treated With Omalizumab

European Annals of Allergy and Clinical Immunology
AllergyImmunology
2017English

Effects of Omalizumab on Chronic Urticaria Not Responding to Recommended Therapy

Allergy, Asthma and Clinical Immunology
ImmunologyPulmonaryAllergyRespiratory Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy